Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-24-049894
Filing Date
2024-12-19
Accepted
2024-12-19 06:16:20
Documents
8
Effectiveness Date
2024-12-19

Document Format Files

Seq Description Document Type Size
1 S-8 ef20040301_s8.htm S-8 53919
2 EXHIBIT 5.1 ef20040301_ex5-1.htm EX-5.1 30307
3 EXHIBIT 23.1 ef20040301_ex23-1.htm EX-23.1 1979
4 EXHIBIT 99.1 ef20040301_ex99-1.htm EX-99.1 368486
5 EXHIBIT 99.2 ef20040301_ex99-2.htm EX-99.2 117973
6 EXHIBIT 107 ef20040301_ex107.htm EX-FILING FEES 74723
7 image00001.jpg GRAPHIC 5595
8 image00002.jpg GRAPHIC 5728
  Complete submission text file 0001140361-24-049894.txt   664249
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283917 | Film No.: 241560916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)